BioCis Pharma Starts Phase IIa Trial in Psoriasis

BioCis Pharma Starts Phase IIa Trial in Psoriasis

TURKU, Finland, March 12 /PRNewswire/ -- BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical…
Permanent vs. Contract

Permanent vs. Contract

LONDON, March 12 /PRNewswire/ -- - Permanent IT Roles in Higher Demand According to Research From The IT Job Board Permanent IT jobs are in more demand than contract positions, according to research…
Epitiro Launches LTE Test Suite

Epitiro Launches LTE Test Suite

CARDIFF, Wales, March 12 /PRNewswire/ -- - World's First IP-Focused Laboratory and In-Life LTE Test Solution Epitiro, the broadband communications authority, today announces the LTE Test Suite, the…